KARINA MERCADO: Open Payments
NPI 1477006393 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 107 payments from 28 companies in 2025. Trend: 2023 $623 · 2024 $1,070 · 2025 $1,902
Food & beverage: $1,902
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $231 |
| Amgen Inc. | 18 | $229 |
| Dexcom, Inc. | 13 | $222 |
| ABBVIE INC. | 13 | $209 |
| Corcept Therapeutics | 9 | $192 |
| TOLMAR, INC. | 5 | $86 |
| Amneal Pharmaceuticals LLC | 3 | $63 |
| CeQur Corporation | 1 | $61 |
| Ascensia Diabetes Care Us Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
Products named: Dexcom G6 Transmitter, Korlym, UBRELVY, Rybelsus, Wegovy, JATENZO, REPATHA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
